Fracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfecta

Osteogenesis imperfecta (OI) is a heritable bone dysplasia characterized by increased skeletal fragility. Patients are often treated with bisphosphonates to attempt to reduce fracture risk. However, bisphosphonates reside in the skeleton for many years and long-term administration may impact bone ma...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Meganck, J.A., Begun, D.L., McElderry, J.D., Swick, A., Kozloff, K.M., Goldstein, S.A., Morris, M.D., Marini, J.C., Caird, M.S.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2013
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3999166/
https://ncbi.nlm.nih.gov/pubmed/23774443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2013.06.003
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg